Ifosfamide/Methylthioninium Chloride Hydrate

异环磷酰胺/亚甲蓝

Report date: 2022/03/23 14:30:12

Base Information

Drug NameIfosfamide/Methylthioninium Chloride Hydrate
Drug Alias NameIfosfamide/Methylthioninium Chloride异环磷酰胺+亚甲蓝ifosfamide + methylthioninium chloride亚甲蓝+异环磷酰胺Methylthioninium Chloride/Ifosfamide +[9
ClassificationSmall molecules
Mechanisms of ActionAlkylating agentsDNA inhibitors
TargetsDNA
Therapy Area/IndicationsSmall Cell Lung CarcinomaSarcoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes IfosfamideMethylene blue
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCelltech
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCelltech
Active IndicationsN/A
Inactive IndicationsSmall Cell Lung CarcinomaSarcoma

Other Information

ATC CodeN/A
Related LinksN/A